HB 1719-FN (2026): removing Hepatitis B from the list of diseases for which immunization is required under state law.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “HB 1719-FN (2026): removing Hepatitis B from the list of diseases for which immunization is required under state law.” Granite Record, https://graniterecord.org/bill/2026/hb1719. Accessed 19 Oct. 2026.
APA: Granite Record. (n.d.). HB 1719-FN (2026): removing Hepatitis B from the list of diseases for which immunization is required under state law. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2026/hb1719
Chicago: Granite Record. “HB 1719-FN (2026): removing Hepatitis B from the list of diseases for which immunization is required under state law.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2026/hb1719.
BibTeX: @misc{bill-2026-hb1719, title = {HB 1719-FN (2026): removing Hepatitis B from the list of diseases for which immunization is required under state law.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2026/hb1719}, note = {Accessed 19 Oct. 2026} }

HB 1719-FN (2026)

removing Hepatitis B from the list of diseases for which immunization is required under state law.

Status: Referred for interim study
Term: 2025-2026
House committee: Health, Human Services and Elderly Affairs
Senate committee: Health and Human Services
Subject: Public and Mental Health

The Story

It was introduced on January 7, 2026 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on January 14, 2026, with 492 people signed in online: 190 in support and 302 in opposition. The committee met in executive session on January 28, 2026 to vote on its recommendation. The majority recommended that the House pass it, and the minority recommended that the House kill it, by a vote of 10–8. The report was placed on the regular calendar. On February 12, 2026 the House voted to pass it on a roll call 186–168. On February 12, 2026 the bill was referred to the Finance committee, whose chair waived the referral under House Rule 47(f). It crossed to the Senate and was referred to the Senate Health and Human Services committee. The committee held a public hearing on April 2, 2026. The committee voted 3–1 to recommend that the Senate study it after the session ends, and the report was placed on the consent calendar. On May 7, 2026 the Senate adopted “Refer to Interim Study” on a voice vote.

Hearings and Sessions

January 14, 2026, 10:30 AM: public hearing, House Health, Human Services and Elderly Affairs, GP 158
January 28, 2026, 2:30 PM: executive session, House Health, Human Services and Elderly Affairs, GP 158
February 12, 2026: floor debate, House
April 2, 2026, 1:00 PM: hearing, Senate Health and Human Services, SH 103
May 7, 2026: consent calendar, Senate

Votes

February 12, 2026, House: Ought to Pass — yeas 186, nays 168, passed
May 7, 2026, Senate: Refer to Interim Study — voice vote, passed

The Docket

January 7, 2026: Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs
January 14, 2026: Public Hearing: 01/14/2026 10:30 am GP 158
January 28, 2026: Executive Session: 01/28/2026 02:30 pm GP 158
January 28, 2026: Majority Committee Report: Ought to Pass 01/28/2026 (Vote 10-8; RC)
February 3, 2026: Minority Committee Report: Inexpedient to Legislate
February 5, 2026: Introduced 02/05/2026 and Referred to Health and Human Services
February 12, 2026: Ought to Pass: MA RC 186-168 02/12/2026
February 12, 2026: Referred to Finance 02/12/2026
March 10, 2026: Referral Waived by Committee Chair per House Rule 47(f) 02/12/2026
April 2, 2026: Hearing: 04/02/2026, Room 103, SH, 01:00 pm
May 7, 2026: Committee Report: Referred to Interim Study, 05/07/2026; Vote 3-1; CC
May 7, 2026: Refer to Interim Study, MA, VV; 05/07/2026

Laws It Would Change

RSA 141-C:20-a